Author:
Gyawali Bishal,Carson Laura M.,Berry Scott,Moraes Fabio Y.
Funder
Conquer Cancer Foundation
Ontario Institute for Cancer Research
Reference9 articles.
1. The ethics of global clinical trials;Weigmann;EMBO Rep,2015
2. Closing the door on parachutes and parasites;Lancet Glob Health,2018
3. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial;Sezer;Lancet,2021
4. FDA approval summary: pembrolizumab for treatment of metastatic non-small cell lung cancer: first-line therapy and beyond;Pai-Scherf;Oncologist,2017
5. FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression;FDA,2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献